Lorell Discenza

1.8k total citations
11 papers, 523 citations indexed

About

Lorell Discenza is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Spectroscopy. According to data from OpenAlex, Lorell Discenza has authored 11 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Spectroscopy. Recurrent topics in Lorell Discenza's work include Biosimilars and Bioanalytical Methods (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). Lorell Discenza is often cited by papers focused on Biosimilars and Bioanalytical Methods (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). Lorell Discenza collaborates with scholars based in United States, Germany and Sweden. Lorell Discenza's co-authors include Mary T. Obermeier, Celia D’Arienzo, Timothy Olah, Joan M. Carboni, Mark D. Wittman, Ann Greer, Ricardo M. Attar, Dolatrai M. Vyas, Zheng Yang and Marco M. Gottardis and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Chromatography A and Molecular Cancer Therapeutics.

In The Last Decade

Lorell Discenza

11 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorell Discenza United States 8 274 222 105 81 77 11 523
Lai Wang China 11 183 0.7× 119 0.5× 145 1.4× 46 0.6× 40 0.5× 17 464
Hans Stieltjes Belgium 17 169 0.6× 247 1.1× 154 1.5× 134 1.7× 37 0.5× 26 628
Karsten Denner Germany 11 323 1.2× 208 0.9× 108 1.0× 20 0.2× 94 1.2× 19 660
Kenji Ohwaki Japan 18 341 1.2× 136 0.6× 112 1.1× 122 1.5× 139 1.8× 30 866
Marjorie J. Ray United States 6 359 1.3× 253 1.1× 187 1.8× 264 3.3× 109 1.4× 6 874
Simon Wong United States 13 228 0.8× 77 0.3× 100 1.0× 52 0.6× 54 0.7× 24 438
Hong Lou United States 15 356 1.3× 90 0.4× 287 2.7× 85 1.0× 190 2.5× 31 857
Lu Zhou China 17 314 1.1× 44 0.2× 133 1.3× 82 1.0× 78 1.0× 50 683
Su Sien Ong United States 12 187 0.7× 102 0.5× 200 1.9× 35 0.4× 40 0.5× 15 558
Joshua A. Dubland Canada 12 262 1.0× 73 0.3× 74 0.7× 163 2.0× 231 3.0× 17 792

Countries citing papers authored by Lorell Discenza

Since Specialization
Citations

This map shows the geographic impact of Lorell Discenza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorell Discenza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorell Discenza more than expected).

Fields of papers citing papers by Lorell Discenza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorell Discenza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorell Discenza. The network helps show where Lorell Discenza may publish in the future.

Co-authorship network of co-authors of Lorell Discenza

This figure shows the co-authorship network connecting the top 25 collaborators of Lorell Discenza. A scholar is included among the top collaborators of Lorell Discenza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorell Discenza. Lorell Discenza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Discenza, Lorell, Aaron Balog, Christine Huang, et al.. (2022). Quantification of Linrodostat and its metabolites: Overcoming bioanalytical challenges in support of a discovery Indoleamine 2,3 dioxygenase program. Journal of Chromatography B. 1207. 123305–123305. 2 indexed citations
2.
Mehl, John T., France Landry, Lorell Discenza, et al.. (2021). Quantification of Surrogate Monoclonal Antibodies in Mouse Serum Using LC–MS/MS. Bioanalysis. 13(3). 147–159. 2 indexed citations
3.
Dai, Jun, Chunlei Wang, Sarah C. Traeger, et al.. (2017). The role of chromatographic and chiroptical spectroscopic techniques and methodologies in support of drug discovery for atropisomeric drug inhibitors of Bruton’s tyrosine kinase. Journal of Chromatography A. 1487. 116–128. 15 indexed citations
4.
Discenza, Lorell, Georgia Cornelius, Jinping Gan, et al.. (2016). Ultrasensitive Quantitative LC–MS/MS of an Inhibitor of Apoptosis Protein’s Antagonist in Plasma Using Protein Target Affinity Extraction. Bioanalysis. 8(4). 265–274. 3 indexed citations
5.
Discenza, Lorell, Mary T. Obermeier, Richard A. Westhouse, Timothy Olah, & Celia D’Arienzo. (2012). A Bioanalytical Strategy Utilizing Dried Blood Spot Sampling And Lc–MS/MS in Discovery Toxicology Studies. Bioanalysis. 4(9). 1057–1064. 11 indexed citations
6.
Discenza, Lorell, Celia D’Arienzo, Timothy Olah, & Mohammed Jemal. (2010). LC–MS/MS method using unbonded silica column and aqueous/methanol mobile phase for the simultaneous quantification of a drug candidate and co-administered metformin in rat plasma. Journal of Chromatography B. 878(19). 1583–1589. 14 indexed citations
7.
D’Arienzo, Celia, Qin Ji, Lorell Discenza, et al.. (2010). DBS Sampling Can be Used to Stabilize Prodrugs in Drug Discovery Rodent Studies without the Addition of Esterase Inhibitors. Bioanalysis. 2(8). 1415–1422. 60 indexed citations
8.
Carboni, Joan M., Mark D. Wittman, Zheng Yang, et al.. (2009). BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR. Molecular Cancer Therapeutics. 8(12). 3341–3349. 218 indexed citations
9.
Obermeier, Mary T., Ming Yao, Ashish Khanna, et al.. (2009). In Vitro Characterization and Pharmacokinetics of Dapagliflozin (BMS-512148), a Potent Sodium-Glucose Cotransporter Type II Inhibitor, in Animals and Humans. Drug Metabolism and Disposition. 38(3). 405–414. 154 indexed citations
10.
Zimmermann, Kurt, Mark D. Wittman, Mark G. Saulnier, et al.. (2008). Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 4075–4080. 17 indexed citations
11.
Shi, Yan, Doree Sitkoff, Jing Zhang, et al.. (2008). Design, Structure−Activity Relationships, X-ray Crystal Structure, and Energetic Contributions of a Critical P1 Pharmacophore: 3-Chloroindole-7-yl-Based Factor Xa Inhibitors. Journal of Medicinal Chemistry. 51(23). 7541–7551. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lai Wang Breakdown of academic impact, for papers by Hans Stieltjes Breakdown of academic impact, for papers by Karsten Denner Breakdown of academic impact, for papers by Kenji Ohwaki Breakdown of academic impact, for papers by Marjorie J. Ray Breakdown of academic impact, for papers by Simon Wong Breakdown of academic impact, for papers by Hong Lou Breakdown of academic impact, for papers by Lu Zhou Breakdown of academic impact, for papers by Su Sien Ong Breakdown of academic impact, for papers by Joshua A. Dubland
Rankless by CCL
2026